2nd generation OvPlex panel: Phase II data

In a Phase II biomarker trial using 107 samples from 46 diseased and 61 control subjects, OvPlex 2G was 98.1% accurate. Of the 7 false negative results produced with the CA125 test, OvPlex 2G identif...